Towards personalized medicine for patients with autoimmune diseases: Opportunities and challenges

被引:29
|
作者
Tavakolpour, Soheil [1 ,2 ,3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Genom Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Autoimmune Bullous Dis Res Ctr, Tehran, Iran
[3] USERN, NIIMA, Tehran, Iran
关键词
Personalized medicine; Autoimmune disease; Immunology diagnosis; Pharmacogenomics; SYSTEMIC-LUPUS-ERYTHEMATOSUS; INFLAMMATORY-BOWEL-DISEASE; PEMPHIGUS-VULGARIS; THERAPY; BIOMARKERS; PSORIASIS; RITUXIMAB; CORTICOSTEROIDS; USTEKINUMAB; MAINTENANCE;
D O I
10.1016/j.imlet.2017.08.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is generally no cure for autoimmune disorders, but the symptoms can be managed. Currently available drugs/treatments are more potent than those in the past decades. However, finding the right drug and right patients has remained a serious problem. We should revise our diagnosis criteria to more accurate ones. During the recent years, personalized medicine has attracted much attention. However, it needs to be well-explained for autoimmune diseases. Personalized medicine aims to find the most optimum drugs for a patient. Hence, recognizing the drugs based on genetics and molecular profile of patients, needs a comprehensive protocol. This study attempted to discuss the most practical and effective ways for identifying right patient and right drug. Patients should be divided into subpopulations. According to the last diagnosis criteria and therapeutic options, it was attempted to highlight the gaps or contradictions in current understanding and suggest what the future of research in this area may hold. Various factors could be considered, including genes variants, genes expression, epigenetic alterations, immune responses, and also basic and obvious characteristics (sex, age, ethnic, etc.). Moreover, advantages, disadvantages, obstacles, and opportunities during the personalized medicine for auto immune diseases have been discussed in great detail. Finally, creation of a global library that covers all the aspects of personalized medicines for different types of autoimmune disease was suggested. In conclusion, revising diagnosis and treatments of autoimmune diseases toward personalized medicine could be the revolutionary step for having more effective and safer therapeutic options.
引用
收藏
页码:130 / 138
页数:9
相关论文
共 50 条
  • [31] Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges
    Fang, Yang
    Ni, Jing
    Wang, Yun-Sheng
    Zhao, Yan
    Jiang, Ling-Qiong
    Chen, Cong
    Zhang, Ruo-Di
    Fang, Xi
    Wang, Peng
    Pan, Hai-Feng
    AUTOIMMUNITY REVIEWS, 2023, 22 (03)
  • [32] Autoimmune protocol diet: A personalized elimination diet for patients with autoimmune diseases
    Pardali, Eleni C.
    Gkouvi, Arriana
    Gkouskou, Kalliopi K.
    Manolakis, Anastasios C.
    Tsigalou, Christina
    Goulis, Dimitrios G.
    Bogdanos, Dimitrios P.
    Grammatikopoulou, Maria G.
    METABOLISM OPEN, 2025, 25
  • [33] Towards precision nephrology: the opportunities and challenges of genomic medicine
    Jordan G. Nestor
    Emily E. Groopman
    Ali G. Gharavi
    Journal of Nephrology, 2018, 31 : 47 - 60
  • [34] Towards precision nephrology: the opportunities and challenges of genomic medicine
    Nestor, Jordan G.
    Groopman, Emily E.
    Gharavi, Ali G.
    JOURNAL OF NEPHROLOGY, 2018, 31 (01) : 47 - 60
  • [35] From big data analysis to personalized medicine for all: challenges and opportunities
    Alyass, Akram
    Turcotte, Michelle
    Meyre, David
    BMC MEDICAL GENOMICS, 2015, 8
  • [36] Challenges and opportunities to bridge translational to clinical research for personalized mitochondrial medicine
    Gropman, Andrea L.
    Uittenbogaard, Martine N.
    Chiaramello, Anne E.
    NEUROTHERAPEUTICS, 2024, 21 (01)
  • [37] Challenges and opportunities in building a health economic framework for personalized medicine in oncology
    Aguiar, Pedro Nazareth
    Matsas, Silvio
    Dienstmann, Rodrigo
    Ferreira, Carlos Gil
    PERSONALIZED MEDICINE, 2023, 20 (05) : 453 - 460
  • [38] From big data analysis to personalized medicine for all: challenges and opportunities
    Akram Alyass
    Michelle Turcotte
    David Meyre
    BMC Medical Genomics, 8
  • [39] Personalized Medicine and Opioid Analgesic Prescribing for Chronic Pain: Opportunities and Challenges
    Bruehl, Stephen
    Apkarian, A. Vania
    Ballantyne, Jane C.
    Berger, Ann
    Borsook, David
    Chen, Wen G.
    Farrar, John T.
    Haythornthwaite, Jennifer A.
    Horn, Susan D.
    Iadarola, Michael J.
    Inturrisi, Charles E.
    Lao, Lixing
    Mackey, Sean
    Mao, Jianren
    Sawczuk, Andrea
    Uhl, George R.
    Witter, James
    Woolf, Clifford J.
    Zubieta, Jon-Kar
    Lin, Yu
    JOURNAL OF PAIN, 2013, 14 (02): : 103 - 113
  • [40] MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine
    Martino, Elisa
    D'Onofrio, Nunzia
    Anastasio, Camilla
    Abate, Marianna
    Zappavigna, Silvia
    Caraglia, Michele
    Balestrieri, Maria Luisa
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2023, 32 : 371 - 384